BIOLASE Inc
OTC:BIOLQ
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
BIOLASE Inc
Income from Continuing Operations
BIOLASE Inc
Income from Continuing Operations Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Income from Continuing Operations | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
BIOLASE Inc
OTC:BIOLQ
|
Income from Continuing Operations
-$16m
|
CAGR 3-Years
2%
|
CAGR 5-Years
6%
|
CAGR 10-Years
1%
|
|
|
Boston Scientific Corp
NYSE:BSX
|
Income from Continuing Operations
$3.6B
|
CAGR 3-Years
58%
|
CAGR 5-Years
70%
|
CAGR 10-Years
N/A
|
|
|
Edwards Lifesciences Corp
NYSE:EW
|
Income from Continuing Operations
$1.1B
|
CAGR 3-Years
-10%
|
CAGR 5-Years
5%
|
CAGR 10-Years
8%
|
|
|
Stryker Corp
NYSE:SYK
|
Income from Continuing Operations
$3.2B
|
CAGR 3-Years
11%
|
CAGR 5-Years
15%
|
CAGR 10-Years
8%
|
|
|
Abbott Laboratories
NYSE:ABT
|
Income from Continuing Operations
$6.3B
|
CAGR 3-Years
3%
|
CAGR 5-Years
2%
|
CAGR 10-Years
11%
|
|
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
Income from Continuing Operations
$2.9B
|
CAGR 3-Years
29%
|
CAGR 5-Years
22%
|
CAGR 10-Years
17%
|
|
BIOLASE Inc
Glance View
BIOLASE, Inc. is a medical device company, which engages in the developing, manufacturing, marketing and sale of laser systems in dentistry and medicine. The company is headquartered in Foothill Ranch, California and currently employs 158 full-time employees. The firm develops, manufactures, markets and sells laser systems, which provides helps to dental practitioners and their patients. The Company’s systems allow dentists, periodontists, endodontists, pediatric dentists, oral surgeons and other dental specialists to perform a range of dental procedures, including cosmetic, restorative and complex surgical applications. The company offers two categories of laser system products: Waterlase (all-tissue) systems and diode (soft tissue) systems. Its Waterlase brand uses a patented combination of water and laser energy and performs using drills, scalpels and other traditional dental instruments for cutting soft and hard tissue. The company offers its diode laser systems to perform soft tissue, pain therapy and cosmetic procedures, including teeth whitening. The company has approximately 301 issued and 38 pending United States and international patents.
See Also
What is BIOLASE Inc's Income from Continuing Operations?
Income from Continuing Operations
-16m
USD
Based on the financial report for Sep 30, 2024, BIOLASE Inc's Income from Continuing Operations amounts to -16m USD.
What is BIOLASE Inc's Income from Continuing Operations growth rate?
Income from Continuing Operations CAGR 10Y
1%
Over the last year, the Income from Continuing Operations growth was 36%. The average annual Income from Continuing Operations growth rates for BIOLASE Inc have been 2% over the past three years , 6% over the past five years , and 1% over the past ten years .
